PML risk stratification using anti-JCV antibody index and L-selectin

Conclusions:
Both JCV index and CD62L have merit for risk stratification and share a potential biological relationship with implications for general PML etiology. A risk algorithm incorporating both biomarkers could strongly reduce PML incidence.

Source: Multiple Sclerosis - July 5, 2016 Category: Neurology Authors: Schwab, N., Schneider-Hohendorf, T., Pignolet, B., Spadaro, M., Görlich, D., Meinl, I., Windhagen, S., Tackenberg, B., Breuer, J., Canto, E., Kümpfel, T., Hohlfeld, R., Siffrin, V., Luessi, F., Posevitz-Fejfar, A., Montalban, X., Meuth, S. Tags: Original Research Papers Source Type: research